Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Joint ESMO-SITC Immunotherapy Primer

The microbiome influence on the TME


07 Dec 2022


Joint ESMO-SITC Immunotherapy Primer


Tumour Immunology;  Immunotherapy

Tumour Site

Genitourinary Cancers;  Thoracic Malignancies


Laurence Zitvogel


L. Zitvogel

Author affiliations

  • Institut Gustave Roussy, Villejuif/FR


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.